← Product Code [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB) · K053261 # ORTHOFIX TITANIUM NAILING SYSTEMS (K053261) _Orthofix Srl · HSB · Dec 12, 2005 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K053261 ## Device Facts - **Applicant:** Orthofix Srl - **Product Code:** [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB.md) - **Decision Date:** Dec 12, 2005 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3020 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use Each nail within the Orthofix Titanium Nailing System is intended for insertion into the medullary canal of a specific long bone - humerus, femur and tibia for the alignment, stabilization and fixation of various types of fractures or deformities caused by trauma or disease. These include: traumatic fractures, re-fractures, non-union, reconstruction, malunion, malalignment, pathological fractures and impending pathological fractures. ## Device Story Orthofix Titanium Nailing System comprises titanium alloy intramedullary nails, locking screws, and accessories (end caps, nuts, washers). System treats long bone fractures (humerus, femur, tibia). Nails vary in diameter, shape, and curvature; may be cannulated. Locking screws provide fixation points tailored to fracture type. Instrumentation provided for insertion and removal. Used by surgeons in clinical/OR settings for fracture stabilization and alignment. Benefits include customized fragment adaptation and mechanical support for bone healing. ## Clinical Evidence No clinical data provided; substantial equivalence is based on design, material, and intended use comparisons. ## Technological Characteristics Materials: Titanium alloy. Components: Intramedullary nails, locking screws, end caps, nuts, washers. Design: Cannulated, straight, curved, or bent configurations. Energy source: None (mechanical). Connectivity: None. Sterilization: Not specified. ## Regulatory Identification An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## DEC 1 2 2005 2/2 # 510(k) Summary of Safety and Effectiveness ## Orthofix Titanium Nailing System 510(k) K053261 - 1. General Information: | Proprietary Name | Orthofix Titanium Nailing System | |-----------------------|------------------------------------------------------------------------------------| | Common Name | Intramedullary Nail | | Regulatory Class | II | | Device Classification | 87HSB (21 CFR 888.3020)
87JDS (21 CFR 888.3030) | | Submitter | R. Sheridan Consulting, LLC
632 Dundee Drive
Wilmington
N.C. 28405
USA | | Registration number | 9680825 | | Contact Person | Rolando Stanghellini
Via delle Nazioni 9
37012 Bussolengo (VR)
Italy | Summary Preparation Date November 15th, 2005 #### 2. Description The Orthofix Titanium Nailing system consists of intramedullary nails, locking screws and additional implantable components made of a titanium alloy. The nails included in the system are designed to treat several types of fractures of the humerus, femur and tibia. Nails come in various shapes and diameters and can be cannulated, straight, curved or with a bend. {1}------------------------------------------------ All nails are locked with various types of locking screws, specifically designed for the type of nail and fracture treated. Nails might have several locking options (varying in number and direction of fixation points and type of screws to be inserted), thus allowing a customized fragment adapted approach. Accessories include end caps, nuts and washers. Instrumentation is available for the insertion and removal of nails, screws and end caps. ### 3. Intended Use Each nail within the Orthofix Titanium Nailing System is intended for insertion into the medullary canal of a specific long bone - humerus, femur and tibia for the alignment, stabilization and fixation of various types of fractures or deformities caused by trauma or disease. These include: traumatic fractures, re-fractures, non-union, reconstruction, malunion, malalignment, pathological fractures and impending pathological fractures. ### 4. Substantial equivalence Documentation is provided which demonstrates the Orthofix Titanium Nailing System to be substantially equivalent to other legally marketed devices. The nails included in the Orthofix Titanium Nailing system and the predicate devices are all intramedullary fracture fixation systems as defined in 21 CFR 888.3020, furthermore, the size, shape and materials for the subject devices are comparable to the predicate devices. #### 5. Conclusion Based upon the similarities in design, materials and intended uses of the Orthofix Titanium Nailing System is substantially equivalent to the predicate devices. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features the department's name in a circular arrangement around an emblem. The emblem consists of a stylized caduceus, a symbol often associated with medicine and healthcare, with three figures intertwined. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC 1 2 2005 Orthofix SRL c/o Candace F. Cederman Sheridan Consulting, LLC 632 Dundee Drive Wilmington, NC 28405 Re: K053261 Trade/Device Name: Orthofix Titanium Nailing System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: II Product Code: HSB, JDS Dated: November 21, 2005 Received: November 22, 2005 Dear Ms. Cederman: We have reviewed your Section 510(k) premarket notification of intent to market the device we nave feviewed your Bectorn of the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encreativent date of the Medical Device Amendments, or to conninered provided in accordance with the provisions of the Federal Food, Drug. de vices marchave been receasined to trequire approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, dicrerore, mains of the Act include requirements for annual registration, listing of general condors provisions of wactice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (600 a0070) ... Existing major regulations affecting your device can inay be subject to satil additions, Title 21, Parts 800 to 898. In addition, FDA may be found in the Coursements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean I lease be advised that 1191 of issuality a vour device complies with other requirements of the Act that I DA has made a sond regulations administered by other Federal agencies. You must of any it cach statutes and regaranents, including, but not limited to: registration and listing (21 comply with an the Act 31equirements) november 19, 2006 manufacturing practice requirements as set forth in the quality systems (QS) regulation (2) CFR Part 820); and if applicable, the electronic (200 forul in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Candace F. Cederman This letter will allow you to begin marketing your device as described in your Section 510(k) I mo reast notification. The FDA finding of substantial equivalence of your device to a legally promated predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Signature Cor Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ #### Indications for Use 510(k) Number (if known): __K053261 Orthofix Titanium Nailing System Device Name: Indications for Use: Each nail within the Orthofix Titanium Nailing System is intended for insertion into the medullary canal of a specific long bone - humerus, femur and tibia for the alignment, stabilization and fixation of various types of fractures or lor the alignment, othe trauma or disease. These include: traumatic fractures, re-fractures, non-union, reconstruction, malunion, malalignment, pathological fractures and impending pathological fractures. Over-The-Counter Use × Prescription Use _____________________________________________________________________________________________________________________________________________________________ AND/OR (21 CFR 801 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of General, Restorative, 2 . I Neurological Devices Page 1 of 1 : Number_KOS3261 --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K053261](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K053261) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com